Point72 Asia (Singapore)’s Relmada Therapeutics RLMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-49,882
Closed -$232K 1430
2024
Q1
$232K Buy
+49,882
New +$232K 0.06% 368